Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LABCORP HOLDINGS INC. Director's Dealing 2021

Feb 4, 2021

30237_dirs_2021-02-04_9f60e147-3b9b-47cd-ae20-20d4fb865019.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2021-02-02

Reporting Person: ANDERSON KERRII B (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-12-03 Common Stock G 746 Disposed 18894 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-02-02 Restricted Stock Unit $ A 771 Acquired Common Stock (771) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 720 Indirect

Footnotes

F1: Amount reflects annuity payment of 480 shares made by the reporting person's grantor retained annuity trust to the reporting person on September 23, 2020.

F2: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F3: The Restricted Stock Units vest fully on February 2, 2022.

F4: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.